医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Cook Medical Names Jean-Marc Creissel Vice President of Operations in Greater China

2016年09月01日 AM02:00
このエントリーをはてなブックマークに追加


 

BLOOMINGTON, Ind.

Cook Medical is pleased to announce that Jean-Marc Creissel has been named vice president of operations for the greater China region. In his new role, Creissel will work with the global and regional teams in APAC to expand the availability of Cook products in that market.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160831006097/en/

Jean-Marc Creissel, Cook Medical (Photo: Business Wire)

Jean-Marc Creissel, Cook Medical (Photo: Business Wire)

Since 2010, Creissel has served as global leader of the Urology business unit and was named vice president of the division in 2014. While assuming this new role, Creissel will continue his global responsibility for sales and marketing, product development, financial performance and general management of the Urology division.

“For the past six years, Jean-Marc has done tremendous work to lead our Urology team,” said Pete Yonkman, president of Cook Medical and Cook Group. “Under his leadership, the division has experienced steady growth every year. His passion for making Cook a stone management solution partner for physicians has not only led to the launch of new products but also to innovative delivery systems that provide physicians the capability to treat patients around the world.”

Creissel joined Cook as a sales representative in Paris in 1990. Since then, he has served in a variety of sales and product management roles, including global director of product management as well as sales and marketing manager for Europe, the Middle East, and Africa.

Creissel moved to the U.S. in 2008 and will relocate to Hong Kong for his new role. He received his state doctorate in pharmacy from the Université Paris Descartes in Paris, France.

About Cook Medical

Since 1963 Cook Medical has worked closely with physicians to develop technologies that eliminate the need for open surgery. Today we are combining medical devices, biologic materials and cellular therapies to help the world’s healthcare systems deliver better outcomes more efficiently. We have always remained family owned so that we have the freedom to focus on what we care about: patients, our employees and our communities. Find out more at www.cookmedical.com, and for the latest news, follow us on Twitter, Facebook and LinkedIn.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160831006097/en/

CONTACT

Cook Medical
Moriah Sowders
Content Specialist, Public
Relations & Social Media
812-340-4347 (mobile)
812-339-2235,
ext. 104357 (office)
moriah.sowders@cookmedical.com

同じカテゴリーの記事 

  • La Jolla Institute for Immunology and RevolKa started a Research Collaboration
  • U.S. FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease
  • ESCMID Global 2024: Shionogi presents real-world data demonstrating efficacy of Fetcroja® / Fetroja® (cefiderocol) in critically ill patients with certain difficult-to-treat bacterial infections
  • Renesas’ New FemtoClock™ 3 Timing Solution Delivers Industry’s Lowest Power and Leading Jitter Performance of 25fs-rms
  • 成人向け予防接種プログラムは初期投資の19倍もの社会経済的価値をもたらすとの新レポートを発表